GEIST WYATT D. (Chief Innovation Officer) purchased 14.1% of their position (19.45K shares) of TENON MEDICAL, INC. on the open market
Open‑market purchases signal personal conviction — classified as a moderate purchase.
P · 1 purchase
Filed: 11/18/2025ACC: 0001213900-25-112296
Officer· Chief Innovation Officer
Since Aug 2025
+38.91K
Net shares
Net buyer
$0.00
Total acquired
1
Open market trades
1B · 0S
2
Total transactions
38.91K acquired
Non-Derivative Transactions1
Common stock
Direct
Shares
+19.45K
Price / share
—
Trade value
—
% of position
14.1%
11/14/2025
138.11K→157.57K
Total
Net shares
+19.45K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common stock Direct | 11/14/2025 | P · Purchase | +19.45K | — | — | 14.1% | 138.11K | 157.57K |
| Total | +19.45K | $0.00 | ||||||
Derivative Transactions1
Common Stock Purchase Warrant
Direct
Converts to
Common Stock
19.45K shares
Shares
+19.45K
Strike price
1.16
Held after
19.45K
Exercisable
—
11/14/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Common Stock Purchase Warrant Direct | Common Stock19.45K shares | 11/14/2025 | P · Purchase | +19.45K | 1.16 | — | 19.45K |
Non-Derivative Holdings (Post-Transaction)1
Common stock
IndirectShares owned350.76K
Total
350.76K indirect350.76K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common stock | 350.76K | Indirect |
| Total | 350.76K | 350.76K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported